Brief: Oncoarendi Therapeutics Project Qualifies For Subsidy Of About 22 Mln Zlotys From Poland's NCBiR

Molecure SA

29/01/2020 15:48

Jan 29 (Reuters) - Oncoarendi Therapeutics SA  OAT.WA :
    * CO'S PROJECT QUALIFIES FOR SUBSIDY OF ABOUT 22 MILLION
ZLOTYS
FROM POLAND'S NATIONAL CENTRE FOR RESEARCH AND DEVELOPMENT
(NCBIR)
    * TOTAL COST OF CO'S PROJECT TO AMOUNT TO ABOUT 31 MILLION
ZLOTYS
    * CO'S PROJECT IS FOR FINDING AND DEVELOPING DEUBIQUITINASE
INHIBITORS FOR USE IN CANCER IMMUNOTHERAPY

Source text for Eikon:  ID:nEM4Fw8d3a 
Further company coverage:  OAT.WA 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))